{"product_id":"middle-east-africa-sepsis-diagnostics-market-forecast-to-2028-covid-19-impact-and-regional-analysis-by-product-instruments-reagents-and-assays-blood-culture-media-and-software-technology-molecular-diagnostics-polymerase-chain-reaction-pepti","title":"Middle East \u0026 Africa Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Pepti","description":"\u003cp\u003eMiddle East \u0026amp; Africa Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)\u003c\/p\u003e\n\n\u003cp\u003eThe Middle East \u0026amp; Africa sepsis diagnostics market is expected to grow from US$ 19.20 million in 2021 to US$ 33.35 million by 2028. It is estimated to record a CAGR of 8.2% from 2021 to 2028.\u003c\/p\u003e\n\n\u003cp\u003eRising Technological Advancements in Sepsis Diagnosis to Drive Middle East \u0026amp; Africa Sepsis Diagnostics Market Growth During 2021–2028\u003c\/p\u003e \n\n\u003cp\u003eTechnology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the process of sepsis diagnosis, identification of the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The adoption of molecular diagnostic technology is increasing due to its several advantages, such as high sensitivity, accuracy, and less turnaround time than other technologies. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management. Thus, the rising use of technology such as molecular diagnostics in sepsis diagnosis is a crucial trend followed by emerging key players operating in the Middle East \u0026amp; Africa sepsis diagnostics market .\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa Sepsis Diagnostics Market Overview\u003c\/p\u003e \n\n\u003cp\u003eThe UAE, Saudi Arabia, and South Africa are three major countries in the Middle East \u0026amp; South Africa. The Middle East \u0026amp; Africa sepsis diagnostics market growth is attributed to factors such as growing healthcare expenditure, rising incidence of sepsis diseases, increasing awareness, and the development of innovative diagnostic products by the market players.\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)\u003c\/p\u003e \n\n\u003cp\u003eMiddle East \u0026amp; Africa Sepsis Diagnostics Market Segmentation\u003c\/p\u003e \n\n\u003cp\u003eThe Middle East \u0026amp; Africa sepsis diagnostics market is segmented into product, method, test type, pathogen, end user, and country.\u003c\/p\u003e\n\n\u003cp\u003eBased on product, the Middle East \u0026amp; Africa sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.\u003c\/p\u003e\n\n\u003cp\u003eBased on technology, the Middle East \u0026amp; Africa sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.\u003c\/p\u003e\n\n\u003cp\u003eBased on method, the Middle East \u0026amp; Africa sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.\u003c\/p\u003e\n\n\u003cp\u003eBased on test type, the Middle East \u0026amp; Africa sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.\u003c\/p\u003e\n\n\u003cp\u003eBased on pathogen, the Middle East \u0026amp; Africa sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.\u003c\/p\u003e\n\n\u003cp\u003eBased on end user, the Middle East \u0026amp; Africa sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.\u003c\/p\u003e\n\n\u003cp\u003eBased on country, the Middle East \u0026amp; Africa sepsis diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East \u0026amp; Africa. Saudi Arabia dominated the market share in 2021.\u003c\/p\u003e\n\n\u003cp\u003eAbbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the Middle East \u0026amp; Africa sepsis diagnostics market.\u003c\/p\u003e\n\n\u003cp\u003eReasons to Buy\u003c\/p\u003e\n\n\u003cp\u003eSave and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East \u0026amp; Africa sepsis diagnostics market. \u003cbr\u003e\nHighlights key business priorities in order to assist companies to realign their business strategies. \u003cbr\u003e\nThe key findings and recommendations highlight crucial progressive industry trends in Middle East \u0026amp; Africa sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies. \u003cbr\u003e\nDevelop\/modify business expansion plans by using substantial growth offering developed and emerging markets. \u003cbr\u003e\nScrutinize in-depth Middle East \u0026amp; Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it. \u003cbr\u003e\nEnhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 205 Pages \/ MCW16227561","offer_id":47645973872946,"sku":null,"price":3600.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/middle-east-africa-sepsis-diagnostics-market-forecast-to-2028-covid-19-impact-and-regional-analysis-by-product-instruments-reagents-and-assays-blood-culture-media-and-software-technology-molecular-diagnostics-polymerase-chain-reaction-pepti","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}